Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer
NCT ID: NCT03300284
Last Updated: 2023-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
186 participants
OBSERVATIONAL
2017-08-07
2023-07-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Decision Aid and Thyroid Nodules Management
NCT05264857
Mapping Patient Decision-making in Thyroid Cancer
NCT06411834
Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
NCT06073223
Shared Decision Making in Patients With Thyroid Nodules
NCT02878044
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
NCT05733013
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Thyroid cancer
This study does not involve any intervention, but rather data collection on patient and physician preferences and beliefs, communication, and patient psychological outcomes.
Questionnaires
Quality of Life Questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaires
Quality of Life Questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For Aim 1, adults with recently diagnosed LR-PTC who have not yet made a choice between surgery and AS
* For Aim 2, adults with LR-PTC who made a decision about surgery or AS at least 3 months prior, but no more than 4 years prior to their routine follow-up visit at which they are being recruited for this study.
* Active patients of MSK and participating institutions
Exclusion Criteria
* Patients with clinically suspicious lymphadenopathy in the neck
* Patients with evidence of gross ETE after a biopsy of the papillary thyroid tumor
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjamin Roman, MD
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hartford Healthcare (Data Collection)
Hartford, Connecticut, United States
Memorial Sloan Kettering Monmouth (Consent and Follow up)
Middletown, New Jersey, United States
MAIMONIDES MEDICAL CENTER (Data collection only)
Brooklyn, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Lehigh Valley Health Network
Allentown, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-382
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.